Lastly, we will discuss clinical interventions that can be employed to counteract this IGF-1-deficiency and the tumor-promoting environment of geriatric skin [9], which may provide a way to reduce skin carcinogenic risk in older patients. This evidence concerns the gene IGF1 and neoplasm.